Literature DB >> 22990716

Acarbose treatment enhances mid-regional pro-atrial natriuretic peptide concentrations in non-diabetic individuals: further evidence for a common cardiometabolic pathway?

N Rudovich1, O Pivovarova, A Traberth, A Sparwasser, M O Weickert, W Bernigau, A L Birkenfeld, A M Arafat, A Bergmann, A F H Pfeiffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22990716     DOI： 10.1007/s00125-012-2724-9

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  7 in total

1.  Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies.

Authors:  M Hanefeld; M Cagatay; T Petrowitsch; D Neuser; D Petzinna; M Rupp
Journal:  Eur Heart J       Date:  2004-01       Impact factor: 29.983

2.  B-type natriuretic peptide and glycaemia: an emerging cardiometabolic pathway?

Authors:  P Welsh; J J McMurray
Journal:  Diabetologia       Date:  2012-03-08       Impact factor: 10.122

3.  Effects of acarbose treatment on markers of insulin sensitivity and systemic inflammation.

Authors:  Natalia N Rudovich; Martin O Weickert; Olga Pivovarova; Wolfgang Bernigau; Andreas F H Pfeiffer
Journal:  Diabetes Technol Ther       Date:  2011-04-13       Impact factor: 6.118

4.  B-type natriuretic peptide (BNP) affects the initial response to intravenous glucose: a randomised placebo-controlled cross-over study in healthy men.

Authors:  B B Heinisch; G Vila; M Resl; M Riedl; B Dieplinger; T Mueller; A Luger; G Pacini; M Clodi
Journal:  Diabetologia       Date:  2011-12-13       Impact factor: 10.122

5.  Insulin up-regulates natriuretic peptide clearance receptor expression in the subcutaneous fat depot in obese subjects: a missing link between CVD risk and obesity?

Authors:  Olga Pivovarova; Özlem Gögebakan; Nora Klöting; Andrea Sparwasser; Martin O Weickert; Isam Haddad; Victoria J Nikiforova; Andreas Bergmann; Michael Kruse; Anne-Cathrin Seltmann; Matthias Blüher; Andreas F H Pfeiffer; Natalia Rudovich
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

6.  Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial.

Authors:  Jean-Louis Chiasson; Robert G Josse; Ramon Gomis; Markolf Hanefeld; Avraham Karasik; Markku Laakso
Journal:  JAMA       Date:  2003-07-23       Impact factor: 56.272

7.  Impact of obesity on plasma natriuretic peptide levels.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Peter W F Wilson; Ramachandran S Vasan
Journal:  Circulation       Date:  2004-02-10       Impact factor: 29.690
  7 in total
  2 in total

1.  The effect of diurnal distribution of carbohydrates and fat on glycaemic control in humans: a randomized controlled trial.

Authors:  Katharina Kessler; Silke Hornemann; Klaus J Petzke; Margrit Kemper; Achim Kramer; Andreas F H Pfeiffer; Olga Pivovarova; Natalia Rudovich
Journal:  Sci Rep       Date:  2017-03-08       Impact factor: 4.379

2.  Diet and glycaemia: the markers and their meaning. A report of the Unilever Nutrition Workshop.

Authors:  Marjan Alssema; Hanny M Boers; Antonio Ceriello; Eric S Kilpatrick; David J Mela; Marion G Priebe; Patrick Schrauwen; Bruce H Wolffenbuttel; Andreas F H Pfeiffer
Journal:  Br J Nutr       Date:  2014-12-11       Impact factor: 3.718
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.